Right now, the big story, however, is the involvement of mARC1 in liver disease, more specifically in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The gene discussed is MTARC1; the disease is metabolic dysfunction-associated steatotic liver disease.